home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Alexandra Health System

SHARESHARESHARE
Alexandra Health System (AHS) offers multi-disciplinary and holistic care for the patient’s total well-being. As a healthcare cluster in the north, AHS manages Khoo Teck Puat Hospital and Yishun Community Hospital. AHS is building the Admiralty Medical Centre, Sembawang Primary Care Centre and Woodlands Integrated Health Campus that will be ready progressively from 2017.
SHARESHARESHARE

RELATED NEWS


A series of pharmaceutical and nutraceutical products, besides chemicals, are now being developed from algae. India is a growing market for micro algae such as Spirulina, which is now given as a pharmaceutical product. There is scope for both small-scale (as cottage industries) and large-scale algal farming here. The US-based Algal Foundation aims to promote the power of algae to transform human society and facilitate a future in which algae are a fundamental source of energy, nutrition products...
THEHINDUBUSINESSLINE
READ MORE

LEO Pharma’s Kyntheum (brodalumab) is a novel biologic approved in Europe in July last year, and is the first and only psoriasis treatment to target the L-17 receptor.
By binding to this specific receptor on the cells of the skin, Kyntheum blocks the biological activity of several pro-inflammatory IL-17 cytokines involved in plaque formation, offering a different mechanism of action to all other psoriasis biologics currently available, which target free inflammatory mediators....

PHARMATIMES
READ MORE

Antibiotic-resistant bacteria and antifungal-resistant fungi are a worrying phenomenon. According to a recent study, a new concern may be developing: alcohol-tolerant bacteria. A number of bacteria species are already resistant to a range of antibiotics; the infections they cause are difficult to treat, posing an ever-increasing threat to patients and staff. Because of the growing numbers of so-called superbugs, hospitals have introduced more stringent cleaning routines. Part of the regimen invo...
TIM NEWMAN
READ MORE

Gilead has teamed up with Aelix Therapeutics to trial a combination designed to free people with HIV from the need to take antiretroviral drugs. The planned clinical trial will test Gilead’s TLR7 agonist in combination with Aelix’s T-cell vaccine. Gilead began testing the TLR7 agonist, vesatolimod, in HIV patients in 2016. In animal models, the combination of the drug and a broadly neutralizing antibody suppressed HIV for six months without additional treatment. The early-stage findi...

READ MORE

The new year is starting off with a $74 billion bang. Bristol-Myers Squibb will acquire Celgene Corporation to create a pharma giant with a significant pipeline focused on oncology, inflammatory and immunologic diseases, and cardiovascular disease. The deal comes days ahead of the 37th annual J.P. Morgan Healthcare Conference and, in some ways, mirrors Celgene’s significant $9 billion acquisition of Juno Therapeutics and $7 billion acquisition of San Diego-based Impact Biomedicines at the ...

READ MORE

Have drugmakers misused a decades-old law designed to spur research into rare, neglected diseases? Sen. Chuck Grassley says he aims to find out. The frequent pharma critic says he's investigating whether “unanticipated uses” of the Orphan Drug Act have helped boost U.S. drug prices....

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...